MK

Mukesh Kumar Pandey

Active Director Director DIN 08942732
DIN 08942732 First appointment Oct 2020 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2020
Shareholding value •••• Premium profile

About Mukesh Kumar Pandey

Data last updated:

Mukesh Kumar Pandey is a Director at Bioliz Pharmaceuticals Private Limited (since 2020). The company operates in Chemicals. Bioliz Pharmaceuticals Private Limited reported revenue of ₹48.5 Lakh (FY 2025).

DIN 08942732
Primary Designation Director
Industry Chemicals
First Appointment 30 Oct 2020
Oldest Company Age 6 yrs
Largest company Bioliz Pharmaceuticals Private Limited · ₹48.5 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Oct 20202020₹48.5 Lakh (FY 2025)Active

Board colleagues of Mukesh Kumar Pandey

Directorship timeline

Open interactive timeline →
Bioliz Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Mukesh Kumar Pandey

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mukesh Kumar Pandey

Mukesh Kumar Pandey currently holds 1 directorship: Bioliz Pharmaceuticals Private Limited (Director, since 30 Oct 2020, revenue ₹48.5 Lakh (FY 2025)).

Mukesh Kumar Pandey was first appointed on 30 Oct 2020 as Director at Bioliz Pharmaceuticals Private Limited.

The current boards of Mukesh Kumar Pandey's companies include Gudiya Devi Mukesh Kumar Pandey (Bioliz Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available